Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of cell killing (GO:0031342) | 4.38462779 |
2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.38462779 |
3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.32940604 |
4 | cellular extravasation (GO:0045123) | 4.28245058 |
5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.26814478 |
6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.26814478 |
7 | modulation by symbiont of host immune response (GO:0052553) | 4.26814478 |
8 | positive regulation by symbiont of host defense response (GO:0052509) | 4.26814478 |
9 | modulation by symbiont of host defense response (GO:0052031) | 4.26814478 |
10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.26814478 |
11 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.12590440 |
12 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.10459673 |
13 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.10459673 |
14 | negative regulation of T cell mediated immunity (GO:0002710) | 3.95481920 |
15 | detection of other organism (GO:0098543) | 3.90575555 |
16 | activated T cell proliferation (GO:0050798) | 3.87491285 |
17 | positive thymic T cell selection (GO:0045059) | 3.83530623 |
18 | macrophage activation involved in immune response (GO:0002281) | 3.80602733 |
19 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.78996154 |
20 | regulation of gamma-delta T cell activation (GO:0046643) | 3.75781448 |
21 | negative regulation of interleukin-12 production (GO:0032695) | 3.72310588 |
22 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.72304686 |
23 | neutrophil activation involved in immune response (GO:0002283) | 3.70552257 |
24 | detection of molecule of bacterial origin (GO:0032490) | 3.64751976 |
25 | detection of bacterium (GO:0016045) | 3.59441246 |
26 | cellular response to interleukin-15 (GO:0071350) | 3.55859767 |
27 | alpha-linolenic acid metabolic process (GO:0036109) | 3.52697848 |
28 | T cell migration (GO:0072678) | 3.51997982 |
29 | response to muramyl dipeptide (GO:0032495) | 3.46569537 |
30 | detection of external biotic stimulus (GO:0098581) | 3.45638156 |
31 | positive regulation of histone deacetylation (GO:0031065) | 3.44545468 |
32 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.44189286 |
33 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.43316484 |
34 | B cell receptor signaling pathway (GO:0050853) | 3.43117706 |
35 | regulation of cholesterol homeostasis (GO:2000188) | 3.42595980 |
36 | positive T cell selection (GO:0043368) | 3.38979233 |
37 | response to peptidoglycan (GO:0032494) | 3.38961188 |
38 | microglial cell activation (GO:0001774) | 3.38945909 |
39 | regulation of tolerance induction (GO:0002643) | 3.37132928 |
40 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.35719308 |
41 | negative T cell selection (GO:0043383) | 3.34016441 |
42 | thymic T cell selection (GO:0045061) | 3.31308157 |
43 | positive regulation of B cell differentiation (GO:0045579) | 3.30779879 |
44 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.29114266 |
45 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.28968264 |
46 | positive regulation of tolerance induction (GO:0002645) | 3.28123816 |
47 | germinal center formation (GO:0002467) | 3.27412623 |
48 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.26720809 |
49 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.26720809 |
50 | positive regulation of granulocyte differentiation (GO:0030854) | 3.26211004 |
51 | regulation of B cell differentiation (GO:0045577) | 3.25595524 |
52 | negative thymic T cell selection (GO:0045060) | 3.23489898 |
53 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.22257488 |
54 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.19063494 |
55 | macrophage activation (GO:0042116) | 3.16961381 |
56 | urea metabolic process (GO:0019627) | 3.16589477 |
57 | urea cycle (GO:0000050) | 3.16589477 |
58 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.16497843 |
59 | neutrophil activation (GO:0042119) | 3.15088066 |
60 | complement activation, alternative pathway (GO:0006957) | 3.14676653 |
61 | detection of biotic stimulus (GO:0009595) | 3.10873487 |
62 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.10858094 |
63 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.10292000 |
64 | myeloid cell activation involved in immune response (GO:0002275) | 3.08842296 |
65 | T cell selection (GO:0045058) | 3.07747424 |
66 | neutrophil mediated immunity (GO:0002446) | 3.07697542 |
67 | phospholipid homeostasis (GO:0055091) | 3.07218545 |
68 | phospholipid efflux (GO:0033700) | 3.07040010 |
69 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.03762131 |
70 | regulation of regulatory T cell differentiation (GO:0045589) | 3.03695965 |
71 | L-phenylalanine catabolic process (GO:0006559) | 3.01581353 |
72 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.01581353 |
73 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.98660502 |
74 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.96769144 |
75 | response to host immune response (GO:0052572) | 2.96769144 |
76 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.95351121 |
77 | protein carboxylation (GO:0018214) | 2.95351121 |
78 | lysine catabolic process (GO:0006554) | 2.93381500 |
79 | lysine metabolic process (GO:0006553) | 2.93381500 |
80 | myeloid leukocyte mediated immunity (GO:0002444) | 2.92754002 |
81 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.89584309 |
82 | response to interleukin-15 (GO:0070672) | 2.87997926 |
83 | granulocyte activation (GO:0036230) | 2.87889069 |
84 | T cell homeostasis (GO:0043029) | 2.87160161 |
85 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.86781615 |
86 | regulation of protein activation cascade (GO:2000257) | 2.85678145 |
87 | negative regulation of fibrinolysis (GO:0051918) | 2.85039519 |
88 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.84911641 |
89 | L-phenylalanine metabolic process (GO:0006558) | 2.84911641 |
90 | negative regulation of adaptive immune response (GO:0002820) | 2.84869562 |
91 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.83761660 |
92 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.83493771 |
93 | respiratory burst (GO:0045730) | 2.82479540 |
94 | positive regulation of lipid catabolic process (GO:0050996) | 2.81360291 |
95 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.80929140 |
96 | growth hormone receptor signaling pathway (GO:0060396) | 2.80854497 |
97 | B cell homeostasis (GO:0001782) | 2.80476677 |
98 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.80220059 |
99 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.79637470 |
100 | response to host (GO:0075136) | 2.79637470 |
101 | response to host defenses (GO:0052200) | 2.79637470 |
102 | kynurenine metabolic process (GO:0070189) | 2.79512439 |
103 | defense response to protozoan (GO:0042832) | 2.78978849 |
104 | valine metabolic process (GO:0006573) | 2.78885844 |
105 | aromatic amino acid family catabolic process (GO:0009074) | 2.78803335 |
106 | regulation of cholesterol storage (GO:0010885) | 2.78211010 |
107 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.77698899 |
108 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.77634126 |
109 | T-helper cell differentiation (GO:0042093) | 2.77634126 |
110 | dendritic cell migration (GO:0036336) | 2.77174852 |
111 | histone H3-K36 demethylation (GO:0070544) | 2.76449587 |
112 | cellular response to type I interferon (GO:0071357) | 2.75863819 |
113 | type I interferon signaling pathway (GO:0060337) | 2.75863819 |
114 | regulation of triglyceride catabolic process (GO:0010896) | 2.75706669 |
115 | immunoglobulin mediated immune response (GO:0016064) | 2.75486134 |
116 | sulfur amino acid catabolic process (GO:0000098) | 2.74980791 |
117 | response to type I interferon (GO:0034340) | 2.74747624 |
118 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.74107942 |
119 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.73802542 |
120 | alpha-beta T cell differentiation (GO:0046632) | 2.73401310 |
121 | nitrogen cycle metabolic process (GO:0071941) | 2.72451000 |
122 | cysteine metabolic process (GO:0006534) | 2.72290616 |
123 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.72206505 |
124 | mast cell activation (GO:0045576) | 2.71882294 |
125 | regulation of complement activation (GO:0030449) | 2.71352278 |
126 | positive regulation of fatty acid oxidation (GO:0046321) | 2.70839683 |
127 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.70827229 |
128 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.70827229 |
129 | T cell receptor signaling pathway (GO:0050852) | 2.70608026 |
130 | plasma lipoprotein particle assembly (GO:0034377) | 2.68049722 |
131 | protein localization to endosome (GO:0036010) | 2.67837319 |
132 | negative regulation of cholesterol transport (GO:0032375) | 2.67179944 |
133 | negative regulation of sterol transport (GO:0032372) | 2.67179944 |
134 | bile acid biosynthetic process (GO:0006699) | 2.66538006 |
135 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.66497344 |
136 | 2-oxoglutarate metabolic process (GO:0006103) | 2.66347855 |
137 | protein-lipid complex assembly (GO:0065005) | 2.61441757 |
138 | high-density lipoprotein particle remodeling (GO:0034375) | 2.59890241 |
139 | low-density lipoprotein particle clearance (GO:0034383) | 2.59557306 |
140 | fatty acid transmembrane transport (GO:1902001) | 2.57267078 |
141 | homocysteine metabolic process (GO:0050667) | 2.56761011 |
142 | plasma lipoprotein particle clearance (GO:0034381) | 2.56426422 |
143 | tryptophan catabolic process (GO:0006569) | 2.53365989 |
144 | indole-containing compound catabolic process (GO:0042436) | 2.53365989 |
145 | indolalkylamine catabolic process (GO:0046218) | 2.53365989 |
146 | regulation of T cell tolerance induction (GO:0002664) | 2.50463069 |
147 | interferon-gamma production (GO:0032609) | 2.48699555 |
148 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.48077787 |
149 | regulation of fibrinolysis (GO:0051917) | 2.47285724 |
150 | tryptophan metabolic process (GO:0006568) | 2.46899637 |
151 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.42791672 |
152 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.42454899 |
153 | amino-acid betaine metabolic process (GO:0006577) | 2.40694706 |
154 | reverse cholesterol transport (GO:0043691) | 2.40528392 |
155 | leukocyte aggregation (GO:0070486) | 2.39319917 |
156 | glyoxylate metabolic process (GO:0046487) | 2.38879729 |
157 | tolerance induction (GO:0002507) | 2.38253983 |
158 | positive regulation of sterol transport (GO:0032373) | 2.37540724 |
159 | positive regulation of cholesterol transport (GO:0032376) | 2.37540724 |
160 | bile acid metabolic process (GO:0008206) | 2.37309650 |
161 | cellular response to growth hormone stimulus (GO:0071378) | 2.35797227 |
162 | positive regulation of humoral immune response (GO:0002922) | 2.35786467 |
163 | positive regulation of p38MAPK cascade (GO:1900745) | 2.34989594 |
164 | response to laminar fluid shear stress (GO:0034616) | 2.34269353 |
165 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.32871733 |
166 | carnitine shuttle (GO:0006853) | 2.32771703 |
167 | negative regulation of lipid transport (GO:0032369) | 2.32116013 |
168 | regulation of fatty acid oxidation (GO:0046320) | 2.31807404 |
169 | ethanol oxidation (GO:0006069) | 2.31766469 |
170 | positive regulation of lipid storage (GO:0010884) | 2.30582280 |
171 | positive regulation of cholesterol efflux (GO:0010875) | 2.28428898 |
172 | cholesterol efflux (GO:0033344) | 2.27192548 |
173 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.26489086 |
174 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.26040806 |
175 | acylglycerol homeostasis (GO:0055090) | 2.25918999 |
176 | triglyceride homeostasis (GO:0070328) | 2.25918999 |
177 | regulation of lipid catabolic process (GO:0050994) | 2.25348534 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.58239776 |
2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.03551021 |
3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.83502843 |
4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.65690734 |
5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.50801758 |
6 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.32285616 |
7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.18571386 |
8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.00916573 |
9 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.99146133 |
10 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.55749286 |
11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.45943312 |
12 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.29977144 |
13 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.28380509 |
14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.26464497 |
15 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.26119147 |
16 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.24720472 |
17 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.22773773 |
18 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.20662903 |
19 | GATA1_22025678_ChIP-Seq_K562_Human | 2.09133977 |
20 | MYC_22102868_ChIP-Seq_BL_Human | 2.06757558 |
21 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.06224930 |
22 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.01344671 |
23 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.00155088 |
24 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.94799109 |
25 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.89895865 |
26 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.89379833 |
27 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.88705851 |
28 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.87075827 |
29 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.81542909 |
30 | MAF_26560356_Chip-Seq_TH1_Human | 1.81037048 |
31 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.78910123 |
32 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.70803432 |
33 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.67629782 |
34 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.67179706 |
35 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.67053031 |
36 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.64141801 |
37 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.63993648 |
38 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.61896920 |
39 | * MYB_26560356_Chip-Seq_TH2_Human | 1.61447097 |
40 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.59685336 |
41 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.59464437 |
42 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.56453989 |
43 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.53115888 |
44 | UTX_26944678_Chip-Seq_JUKART_Human | 1.53106196 |
45 | MYB_26560356_Chip-Seq_TH1_Human | 1.51653844 |
46 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.48886454 |
47 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45505891 |
48 | GATA3_26560356_Chip-Seq_TH2_Human | 1.45134220 |
49 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.43819861 |
50 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.41122781 |
51 | GATA1_19941826_ChIP-Seq_K562_Human | 1.41087830 |
52 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39615877 |
53 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37878602 |
54 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.35618926 |
55 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.34735217 |
56 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.30823198 |
57 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.30631327 |
58 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.29038072 |
59 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.28848029 |
60 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.28733863 |
61 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.27554692 |
62 | GATA2_19941826_ChIP-Seq_K562_Human | 1.25976443 |
63 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.25758167 |
64 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.25152509 |
65 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.24752783 |
66 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.24668089 |
67 | * MAF_26560356_Chip-Seq_TH2_Human | 1.22496532 |
68 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.21483119 |
69 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.20954123 |
70 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.20752985 |
71 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.20142278 |
72 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19382338 |
73 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.18890057 |
74 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16748077 |
75 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16470560 |
76 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.13770698 |
77 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.12863573 |
78 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.11850332 |
79 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11727972 |
80 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.11547885 |
81 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.10058974 |
82 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.09771957 |
83 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.09771957 |
84 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09059403 |
85 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.08657544 |
86 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08599888 |
87 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.07831104 |
88 | SPI1_23127762_ChIP-Seq_K562_Human | 1.06150246 |
89 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05879276 |
90 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.05207551 |
91 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.04620331 |
92 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.03536077 |
93 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02679023 |
94 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02663852 |
95 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.02474517 |
96 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.01422499 |
97 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.00897597 |
98 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.00357402 |
99 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.00147785 |
100 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.99994175 |
101 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.99907126 |
102 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.98514818 |
103 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.98338784 |
104 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.97582904 |
105 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.97523475 |
106 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.97506516 |
107 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.97398269 |
108 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96828040 |
109 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.96641108 |
110 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.96156252 |
111 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.96113027 |
112 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96000675 |
113 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.94585787 |
114 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94482828 |
115 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.94470889 |
116 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.94470889 |
117 | KDM2B_26808549_Chip-Seq_K562_Human | 0.93181621 |
118 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.91591060 |
119 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91324045 |
120 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90391627 |
121 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84746420 |
122 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.83899078 |
123 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.83862059 |
124 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.81397041 |
125 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.80914491 |
126 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.74767472 |
127 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.72417261 |
128 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.72116642 |
129 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.71132529 |
130 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.70921100 |
131 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.70218111 |
132 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.69618951 |
133 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.65213696 |
134 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.62093562 |
135 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.62056543 |
136 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.61907093 |
137 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.61891518 |
138 | GATA3_26560356_Chip-Seq_TH1_Human | 0.60825007 |
139 | TP53_16413492_ChIP-PET_HCT116_Human | 0.58281011 |
140 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.57737191 |
141 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.57011452 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 3.76975840 |
2 | MP0005360_urolithiasis | 3.69039531 |
3 | MP0010234_abnormal_vibrissa_follicle | 3.24250499 |
4 | MP0005365_abnormal_bile_salt | 3.14975202 |
5 | MP0005085_abnormal_gallbladder_physiolo | 2.91043569 |
6 | MP0003300_gastrointestinal_ulcer | 2.88953971 |
7 | MP0003705_abnormal_hypodermis_morpholog | 2.44086500 |
8 | MP0003252_abnormal_bile_duct | 2.41517155 |
9 | MP0003191_abnormal_cellular_cholesterol | 2.35460773 |
10 | MP0003303_peritoneal_inflammation | 2.33330252 |
11 | MP0002138_abnormal_hepatobiliary_system | 2.33057704 |
12 | MP0008875_abnormal_xenobiotic_pharmacok | 2.31441364 |
13 | MP0002166_altered_tumor_susceptibility | 2.23045799 |
14 | MP0003828_pulmonary_edema | 2.15629710 |
15 | MP0004947_skin_inflammation | 2.06827091 |
16 | MP0002148_abnormal_hypersensitivity_rea | 2.05382708 |
17 | MP0000685_abnormal_immune_system | 2.01887850 |
18 | MP0009840_abnormal_foam_cell | 2.01512013 |
19 | MP0010329_abnormal_lipoprotein_level | 1.96769938 |
20 | MP0008260_abnormal_autophagy | 1.92458731 |
21 | MP0004381_abnormal_hair_follicle | 1.88821284 |
22 | MP0003763_abnormal_thymus_physiology | 1.86994638 |
23 | MP0003436_decreased_susceptibility_to | 1.85831482 |
24 | MP0009333_abnormal_splenocyte_physiolog | 1.80555902 |
25 | MP0001790_abnormal_immune_system | 1.79840312 |
26 | MP0005387_immune_system_phenotype | 1.79840312 |
27 | MP0001800_abnormal_humoral_immune | 1.79093768 |
28 | MP0000609_abnormal_liver_physiology | 1.78534345 |
29 | MP0000569_abnormal_digit_pigmentation | 1.76938305 |
30 | MP0001851_eye_inflammation | 1.68766785 |
31 | MP0004510_myositis | 1.67757062 |
32 | MP0004130_abnormal_muscle_cell | 1.65590452 |
33 | MP0003172_abnormal_lysosome_physiology | 1.62291421 |
34 | MP0002006_tumorigenesis | 1.60285340 |
35 | MP0008961_abnormal_basal_metabolism | 1.60259286 |
36 | MP0005083_abnormal_biliary_tract | 1.59589390 |
37 | MP0004185_abnormal_adipocyte_glucose | 1.59342059 |
38 | MP0003566_abnormal_cell_adhesion | 1.57981863 |
39 | MP0005310_abnormal_salivary_gland | 1.56420351 |
40 | MP0010352_gastrointestinal_tract_polyps | 1.48823154 |
41 | MP0001666_abnormal_nutrient_absorption | 1.47856976 |
42 | MP0004883_abnormal_blood_vessel | 1.47191816 |
43 | MP0001835_abnormal_antigen_presentation | 1.45715901 |
44 | MP0005076_abnormal_cell_differentiation | 1.41999362 |
45 | MP0002998_abnormal_bone_remodeling | 1.41597685 |
46 | MP0005000_abnormal_immune_tolerance | 1.39946351 |
47 | MP0002723_abnormal_immune_serum | 1.39893842 |
48 | MP0002452_abnormal_antigen_presenting | 1.38789148 |
49 | MP0009278_abnormal_bone_marrow | 1.36987224 |
50 | MP0002009_preneoplasia | 1.36694000 |
51 | MP0005275_abnormal_skin_tensile | 1.34724921 |
52 | MP0005671_abnormal_response_to | 1.33698936 |
53 | MP0003453_abnormal_keratinocyte_physiol | 1.30400463 |
54 | MP0002420_abnormal_adaptive_immunity | 1.29742524 |
55 | MP0010155_abnormal_intestine_physiology | 1.29629077 |
56 | MP0006082_CNS_inflammation | 1.29612174 |
57 | MP0005666_abnormal_adipose_tissue | 1.29103648 |
58 | MP0001819_abnormal_immune_cell | 1.28422738 |
59 | MP0005464_abnormal_platelet_physiology | 1.28292579 |
60 | MP0002254_reproductive_system_inflammat | 1.27712251 |
61 | MP0002396_abnormal_hematopoietic_system | 1.25918896 |
62 | MP0002796_impaired_skin_barrier | 1.24800325 |
63 | MP0001873_stomach_inflammation | 1.24503636 |
64 | MP0005025_abnormal_response_to | 1.24375990 |
65 | MP0002118_abnormal_lipid_homeostasis | 1.23299454 |
66 | MP0005451_abnormal_body_composition | 1.23117597 |
67 | MP0008057_abnormal_DNA_replication | 1.20294156 |
68 | MP0002419_abnormal_innate_immunity | 1.17261930 |
69 | MP0009785_altered_susceptibility_to | 1.16595917 |
70 | MP0004484_altered_response_of | 1.15335600 |
71 | MP0001845_abnormal_inflammatory_respons | 1.15157601 |
72 | MP0002398_abnormal_bone_marrow | 1.14960795 |
73 | MP0002877_abnormal_melanocyte_morpholog | 1.13663173 |
74 | MP0002933_joint_inflammation | 1.13273096 |
75 | MP0000015_abnormal_ear_pigmentation | 1.13092415 |
76 | MP0000604_amyloidosis | 1.10423604 |
77 | MP0008004_abnormal_stomach_pH | 1.10052770 |
78 | MP0002277_abnormal_respiratory_mucosa | 1.09780311 |
79 | MP0001853_heart_inflammation | 1.09754460 |
80 | MP0003724_increased_susceptibility_to | 1.08963550 |
81 | MP0002405_respiratory_system_inflammati | 1.08082461 |
82 | MP0005075_abnormal_melanosome_morpholog | 1.07950641 |
83 | MP0000716_abnormal_immune_system | 1.07730676 |
84 | MP0005670_abnormal_white_adipose | 1.07726845 |
85 | MP0003045_fibrosis | 1.07663373 |
86 | MP0008469_abnormal_protein_level | 1.07006978 |
87 | MP0000858_altered_metastatic_potential | 1.04217728 |
88 | MP0005319_abnormal_enzyme/_coenzyme | 1.04020305 |
89 | MP0003221_abnormal_cardiomyocyte_apopto | 1.03844635 |
90 | MP0003183_abnormal_peptide_metabolism | 1.01661337 |
91 | MP0005164_abnormal_response_to | 1.00511459 |
92 | MP0005023_abnormal_wound_healing | 0.99315100 |
93 | MP0005332_abnormal_amino_acid | 0.98358369 |
94 | MP0009763_increased_sensitivity_to | 0.98217958 |
95 | MP0003091_abnormal_cell_migration | 0.97692571 |
96 | MP0003868_abnormal_feces_composition | 0.97217235 |
97 | MP0000689_abnormal_spleen_morphology | 0.96458416 |
98 | MP0003690_abnormal_glial_cell | 0.96423391 |
99 | MP0009764_decreased_sensitivity_to | 0.95511738 |
100 | MP0002132_abnormal_respiratory_system | 0.95273494 |
101 | MP0001533_abnormal_skeleton_physiology | 0.93511480 |
102 | MP0002722_abnormal_immune_system | 0.93424306 |
103 | MP0002971_abnormal_brown_adipose | 0.91635323 |
104 | MP0002060_abnormal_skin_morphology | 0.90748851 |
105 | MP0005166_decreased_susceptibility_to | 0.90669535 |
106 | MP0005375_adipose_tissue_phenotype | 0.90560210 |
107 | MP0000598_abnormal_liver_morphology | 0.90516321 |
108 | MP0003656_abnormal_erythrocyte_physiolo | 0.89634055 |
109 | MP0001545_abnormal_hematopoietic_system | 0.88097046 |
110 | MP0005397_hematopoietic_system_phenotyp | 0.88097046 |
111 | MP0000703_abnormal_thymus_morphology | 0.87198133 |
112 | MP0001216_abnormal_epidermal_layer | 0.85777637 |
113 | MP0003787_abnormal_imprinting | 0.85711341 |
114 | MP0009643_abnormal_urine_homeostasis | 0.85045999 |
115 | MP0000465_gastrointestinal_hemorrhage | 0.84643662 |
116 | MP0002429_abnormal_blood_cell | 0.82562295 |
117 | MP0000249_abnormal_blood_vessel | 0.82473233 |
118 | MP0010678_abnormal_skin_adnexa | 0.79962868 |
119 | MP0010368_abnormal_lymphatic_system | 0.79876148 |
120 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.79637935 |
121 | MP0002837_dystrophic_cardiac_calcinosis | 0.79597262 |
122 | MP0004808_abnormal_hematopoietic_stem | 0.79288624 |
123 | MP0005174_abnormal_tail_pigmentation | 0.78480323 |
124 | MP0002928_abnormal_bile_duct | 0.78224409 |
125 | MP0001663_abnormal_digestive_system | 0.78217247 |
126 | MP0010630_abnormal_cardiac_muscle | 0.78158316 |
127 | MP0003806_abnormal_nucleotide_metabolis | 0.78026953 |
128 | MP0002332_abnormal_exercise_endurance | 0.77938136 |
129 | MP0001986_abnormal_taste_sensitivity | 0.75780201 |
130 | MP0003448_altered_tumor_morphology | 0.74378541 |
131 | MP0003866_abnormal_defecation | 0.74234617 |
132 | MP0002168_other_aberrant_phenotype | 0.73486888 |
133 | MP0003075_altered_response_to | 0.73150862 |
134 | MP0002136_abnormal_kidney_physiology | 0.73149793 |
135 | MP0005390_skeleton_phenotype | 0.72981356 |
136 | MP0009115_abnormal_fat_cell | 0.63558423 |
137 | MP0003795_abnormal_bone_structure | 0.60725998 |
138 | MP0005388_respiratory_system_phenotype | 0.60464404 |
139 | MP0002133_abnormal_respiratory_system | 0.60464404 |
140 | MP0009765_abnormal_xenobiotic_induced | 0.57802673 |
141 | MP0006054_spinal_hemorrhage | 0.56882867 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent bacterial skin infections (HP:0005406) | 4.99740226 |
2 | Recurrent abscess formation (HP:0002722) | 4.65876191 |
3 | Optic neuritis (HP:0100653) | 4.41151624 |
4 | Retrobulbar optic neuritis (HP:0100654) | 4.41151624 |
5 | Deep venous thrombosis (HP:0002625) | 4.34512508 |
6 | Orchitis (HP:0100796) | 4.29865386 |
7 | Abnormality of macrophages (HP:0004311) | 3.81713274 |
8 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.61666192 |
9 | Recurrent cutaneous fungal infections (HP:0011370) | 3.61666192 |
10 | Recurrent skin infections (HP:0001581) | 3.59863864 |
11 | Xanthomatosis (HP:0000991) | 3.55926962 |
12 | Mediastinal lymphadenopathy (HP:0100721) | 3.48800406 |
13 | Myocardial infarction (HP:0001658) | 3.45869074 |
14 | Complement deficiency (HP:0004431) | 3.42737054 |
15 | Keratoconjunctivitis sicca (HP:0001097) | 3.37378297 |
16 | Meningitis (HP:0001287) | 3.30860549 |
17 | Intrahepatic cholestasis (HP:0001406) | 3.27004762 |
18 | Encephalitis (HP:0002383) | 3.18878707 |
19 | Keratoconjunctivitis (HP:0001096) | 3.17327070 |
20 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.16986515 |
21 | Gingivitis (HP:0000230) | 3.02258058 |
22 | Leukocytosis (HP:0001974) | 3.01366999 |
23 | Panhypogammaglobulinemia (HP:0003139) | 3.00541439 |
24 | Hemoptysis (HP:0002105) | 2.98356195 |
25 | Pulmonary infiltrates (HP:0002113) | 2.95443989 |
26 | Prolonged bleeding time (HP:0003010) | 2.89850364 |
27 | Chest pain (HP:0100749) | 2.89435764 |
28 | Hyperlipoproteinemia (HP:0010980) | 2.84964033 |
29 | T lymphocytopenia (HP:0005403) | 2.82327977 |
30 | Increased IgE level (HP:0003212) | 2.81891036 |
31 | Abnormality of the common coagulation pathway (HP:0010990) | 2.81826065 |
32 | Papilledema (HP:0001085) | 2.80734529 |
33 | Abnormality of T cell number (HP:0011839) | 2.76583746 |
34 | Autoimmune hemolytic anemia (HP:0001890) | 2.75695580 |
35 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.75678857 |
36 | Chronic obstructive pulmonary disease (HP:0006510) | 2.71944177 |
37 | Obstructive lung disease (HP:0006536) | 2.71944177 |
38 | Abnormality of complement system (HP:0005339) | 2.71586729 |
39 | Abnormality of the fingertips (HP:0001211) | 2.71098283 |
40 | Epidermoid cyst (HP:0200040) | 2.67432773 |
41 | Hematochezia (HP:0002573) | 2.67294417 |
42 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.65047873 |
43 | Cerebral aneurysm (HP:0004944) | 2.59288542 |
44 | Eosinophilia (HP:0001880) | 2.57954499 |
45 | Urticaria (HP:0001025) | 2.54789255 |
46 | Eczematoid dermatitis (HP:0000976) | 2.53554896 |
47 | Granulocytopenia (HP:0001913) | 2.53438875 |
48 | Spontaneous hematomas (HP:0007420) | 2.50172392 |
49 | Stomach cancer (HP:0012126) | 2.49114502 |
50 | Hypoalphalipoproteinemia (HP:0003233) | 2.48299706 |
51 | Slow saccadic eye movements (HP:0000514) | 2.44950699 |
52 | Abnormality of eosinophils (HP:0001879) | 2.43981350 |
53 | Cellulitis (HP:0100658) | 2.41125755 |
54 | Autoimmune thrombocytopenia (HP:0001973) | 2.40088148 |
55 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.38735538 |
56 | Esophageal varix (HP:0002040) | 2.37736503 |
57 | Right ventricular cardiomyopathy (HP:0011663) | 2.37638400 |
58 | Polycythemia (HP:0001901) | 2.36388013 |
59 | Mitral stenosis (HP:0001718) | 2.35383278 |
60 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.34594779 |
61 | Gangrene (HP:0100758) | 2.33662108 |
62 | Abnormality of T cell physiology (HP:0011840) | 2.33364137 |
63 | Hypobetalipoproteinemia (HP:0003563) | 2.32999989 |
64 | Aortic aneurysm (HP:0004942) | 2.31059832 |
65 | Pustule (HP:0200039) | 2.28598774 |
66 | Nasal polyposis (HP:0100582) | 2.28435271 |
67 | Prolonged partial thromboplastin time (HP:0003645) | 2.25774506 |
68 | Abnormality of the nasal mucosa (HP:0000433) | 2.25732469 |
69 | Joint hemorrhage (HP:0005261) | 2.24335278 |
70 | Episodic fever (HP:0001954) | 2.23811351 |
71 | Osteomyelitis (HP:0002754) | 2.23646103 |
72 | Mitral valve prolapse (HP:0001634) | 2.23005334 |
73 | Hypolipoproteinemia (HP:0010981) | 2.22542046 |
74 | Gingival bleeding (HP:0000225) | 2.21383214 |
75 | Ketosis (HP:0001946) | 2.21230289 |
76 | Pulmonary embolism (HP:0002204) | 2.21064509 |
77 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.20380296 |
78 | Papilloma (HP:0012740) | 2.19795527 |
79 | Verrucae (HP:0200043) | 2.19795527 |
80 | Lymphopenia (HP:0001888) | 2.19720860 |
81 | Systemic lupus erythematosus (HP:0002725) | 2.19564703 |
82 | Abnormal platelet volume (HP:0011876) | 2.19451197 |
83 | Severe combined immunodeficiency (HP:0004430) | 2.19321973 |
84 | Hypoglycemic coma (HP:0001325) | 2.17442248 |
85 | Increased mean platelet volume (HP:0011877) | 2.17039194 |
86 | Colitis (HP:0002583) | 2.16005830 |
87 | Hyperammonemia (HP:0001987) | 2.15716490 |
88 | Recurrent viral infections (HP:0004429) | 2.14602123 |
89 | Hyporeflexia of lower limbs (HP:0002600) | 2.14153320 |
90 | Chronic diarrhea (HP:0002028) | 2.13761020 |
91 | Hypercholesterolemia (HP:0003124) | 2.10731858 |
92 | Increased IgM level (HP:0003496) | 2.10487740 |
93 | Hepatocellular carcinoma (HP:0001402) | 2.10042650 |
94 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.09498465 |
95 | Arterial thrombosis (HP:0004420) | 2.08856905 |
96 | Subacute progressive viral hepatitis (HP:0006572) | 2.08846894 |
97 | Gastrointestinal infarctions (HP:0005244) | 2.07349349 |
98 | Anorexia (HP:0002039) | 2.06698058 |
99 | Viral hepatitis (HP:0006562) | 2.06175784 |
100 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.05058968 |
101 | Hypochromic anemia (HP:0001931) | 2.02374635 |
102 | Increased CSF protein (HP:0002922) | 2.01288140 |
103 | Hemorrhage of the eye (HP:0011885) | 2.01129770 |
104 | Abnormality of the pleura (HP:0002103) | 2.00782281 |
105 | Recurrent bronchitis (HP:0002837) | 1.99791825 |
106 | Striae distensae (HP:0001065) | 1.99047153 |
107 | Recurrent fungal infections (HP:0002841) | 1.98415229 |
108 | Hypochromic microcytic anemia (HP:0004840) | 1.97463679 |
109 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.97393621 |
110 | Aneurysm (HP:0002617) | 1.97296656 |
111 | Thyroiditis (HP:0100646) | 1.97031331 |
112 | Agammaglobulinemia (HP:0004432) | 1.95321968 |
113 | Sepsis (HP:0100806) | 1.95000619 |
114 | Abnormality of the endocardium (HP:0004306) | 1.94925260 |
115 | Peritonitis (HP:0002586) | 1.94693294 |
116 | Inflammation of the large intestine (HP:0002037) | 1.93952436 |
117 | Hypergammaglobulinemia (HP:0010702) | 1.93187303 |
118 | Alveolar cell carcinoma (HP:0006519) | 1.92963112 |
119 | Spastic diplegia (HP:0001264) | 1.92843437 |
120 | Nephritis (HP:0000123) | 1.92657851 |
121 | Fat malabsorption (HP:0002630) | 1.91997905 |
122 | Thrombophlebitis (HP:0004418) | 1.91995149 |
123 | IgG deficiency (HP:0004315) | 1.90214742 |
124 | Frequent falls (HP:0002359) | 1.89459975 |
125 | Microcytic anemia (HP:0001935) | 1.87716602 |
126 | Periodontitis (HP:0000704) | 1.86281316 |
127 | Fatigue (HP:0012378) | 1.85652971 |
128 | Gastrointestinal inflammation (HP:0004386) | 1.84600435 |
129 | Macroorchidism (HP:0000053) | 1.82809268 |
130 | Hypoplasia of the thymus (HP:0000778) | 1.82804140 |
131 | Amaurosis fugax (HP:0100576) | 1.82200140 |
132 | Thin bony cortex (HP:0002753) | 1.80678316 |
133 | Skin nodule (HP:0200036) | 1.80369706 |
134 | Myositis (HP:0100614) | 1.80308534 |
135 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.78532690 |
136 | Vertigo (HP:0002321) | 1.78397326 |
137 | Obstructive sleep apnea (HP:0002870) | 1.77831588 |
138 | Vasculitis (HP:0002633) | 1.77637756 |
139 | Keratitis (HP:0000491) | 1.76983993 |
140 | Abnormality of T cells (HP:0002843) | 1.76049668 |
141 | Acanthocytosis (HP:0001927) | 1.75260208 |
142 | Glomerulopathy (HP:0100820) | 1.75026726 |
143 | Joint swelling (HP:0001386) | 1.71208072 |
144 | Increased connective tissue (HP:0009025) | 1.70854337 |
145 | Disproportionate tall stature (HP:0001519) | 1.70607070 |
146 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.69616403 |
147 | Epistaxis (HP:0000421) | 1.68941242 |
148 | Osteolytic defects of the hand bones (HP:0009699) | 1.68814192 |
149 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.68814192 |
150 | Dilatation of the ascending aorta (HP:0005111) | 1.68710667 |
151 | Skin ulcer (HP:0200042) | 1.68031965 |
152 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.68016752 |
153 | Combined immunodeficiency (HP:0005387) | 1.66860640 |
154 | Polyneuropathy (HP:0001271) | 1.66748979 |
155 | Emphysema (HP:0002097) | 1.64739911 |
156 | Abnormality of the intrinsic pathway (HP:0010989) | 1.64539094 |
157 | Interstitial pulmonary disease (HP:0006530) | 1.64274236 |
158 | Increased density of long bones (HP:0006392) | 1.63569322 |
159 | Menorrhagia (HP:0000132) | 1.63394923 |
160 | Abnormality of the Achilles tendon (HP:0005109) | 1.63388242 |
161 | Ketoacidosis (HP:0001993) | 1.62604040 |
162 | Abnormality of proline metabolism (HP:0010907) | 1.62441557 |
163 | Hydroxyprolinuria (HP:0003080) | 1.62441557 |
164 | Glomerulonephritis (HP:0000099) | 1.61704407 |
165 | Stroke (HP:0001297) | 1.61297290 |
166 | Stomatitis (HP:0010280) | 1.60534097 |
167 | Back pain (HP:0003418) | 1.59270029 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 3.40349355 |
2 | TRIB3 | 3.20854453 |
3 | FGFR4 | 2.98168404 |
4 | PKN2 | 2.80605530 |
5 | PRPF4B | 2.68297614 |
6 | MAP3K10 | 2.42785272 |
7 | EEF2K | 2.33926248 |
8 | FES | 2.27042265 |
9 | TYK2 | 2.26370824 |
10 | ITK | 2.14598586 |
11 | ERN1 | 2.08757188 |
12 | JAK1 | 2.08366534 |
13 | IRAK4 | 2.08179515 |
14 | SIK1 | 2.07304036 |
15 | TTN | 2.01285331 |
16 | STK10 | 1.99029455 |
17 | RIPK1 | 1.97304886 |
18 | TXK | 1.93943172 |
19 | PTK6 | 1.92506185 |
20 | GRK6 | 1.85720373 |
21 | FGFR3 | 1.81779587 |
22 | TGFBR2 | 1.75666450 |
23 | MAP3K14 | 1.69362672 |
24 | JAK3 | 1.68971320 |
25 | TAOK3 | 1.56545362 |
26 | IRAK1 | 1.51681478 |
27 | TBK1 | 1.50439689 |
28 | CAMKK2 | 1.44991698 |
29 | SIK3 | 1.44126260 |
30 | ZAP70 | 1.43044757 |
31 | CDK12 | 1.40676125 |
32 | MAP3K7 | 1.40590879 |
33 | EPHB1 | 1.38272379 |
34 | MAP3K13 | 1.34359015 |
35 | LATS1 | 1.33832436 |
36 | CSK | 1.33368622 |
37 | IKBKE | 1.32084524 |
38 | PIK3CG | 1.30962331 |
39 | TNK2 | 1.30726020 |
40 | JAK2 | 1.30051357 |
41 | MAP2K3 | 1.23024323 |
42 | LRRK2 | 1.22249790 |
43 | SGK2 | 1.22149507 |
44 | BMPR2 | 1.20447740 |
45 | CAMK1D | 1.16839917 |
46 | FGR | 1.16571079 |
47 | DMPK | 1.16536902 |
48 | LYN | 1.12986204 |
49 | IRAK2 | 1.10051832 |
50 | KIT | 1.09591339 |
51 | CDK6 | 1.09406264 |
52 | YES1 | 1.09261330 |
53 | MAPK7 | 1.06512510 |
54 | PRKCH | 1.04376460 |
55 | HCK | 1.03877522 |
56 | PDGFRA | 1.02352547 |
57 | FGFR2 | 1.01602148 |
58 | CHUK | 1.00199113 |
59 | MARK2 | 0.99725893 |
60 | EPHA3 | 0.96221879 |
61 | ACVR1B | 0.95741287 |
62 | MAP3K3 | 0.94590674 |
63 | CAMK1G | 0.94077975 |
64 | RET | 0.89652840 |
65 | PDGFRB | 0.89293938 |
66 | SIK2 | 0.89012182 |
67 | FRK | 0.88563338 |
68 | SGK3 | 0.86043045 |
69 | FLT3 | 0.84671471 |
70 | LCK | 0.83957158 |
71 | PRKCQ | 0.83487171 |
72 | BTK | 0.81777597 |
73 | STK24 | 0.80461929 |
74 | CAMKK1 | 0.80332461 |
75 | STK3 | 0.79911713 |
76 | TAOK1 | 0.78747321 |
77 | TEC | 0.74259110 |
78 | BRD4 | 0.73452346 |
79 | MAPK11 | 0.72397759 |
80 | MARK3 | 0.72223516 |
81 | SYK | 0.71473870 |
82 | PIM1 | 0.71374873 |
83 | PTK2 | 0.69434907 |
84 | CSF1R | 0.69311868 |
85 | IKBKB | 0.69251069 |
86 | MTOR | 0.68609281 |
87 | PDK1 | 0.66649810 |
88 | SGK494 | 0.65667297 |
89 | SGK223 | 0.65667297 |
90 | MAP3K2 | 0.65527430 |
91 | CAMK4 | 0.65317323 |
92 | PRKAA2 | 0.65268580 |
93 | MAP3K6 | 0.64322961 |
94 | TNIK | 0.63593891 |
95 | DYRK1B | 0.62276591 |
96 | HIPK2 | 0.61357304 |
97 | NLK | 0.61253745 |
98 | RIPK4 | 0.60471172 |
99 | BCKDK | 0.60432691 |
100 | BLK | 0.58594884 |
101 | STK11 | 0.58320677 |
102 | RPS6KA4 | 0.54999179 |
103 | NEK9 | 0.54927042 |
104 | GRK7 | 0.54042446 |
105 | MAPK12 | 0.53352007 |
106 | MELK | 0.53094390 |
107 | MST1R | 0.52910776 |
108 | PTK2B | 0.52852017 |
109 | NUAK1 | 0.52675504 |
110 | BMX | 0.52149940 |
111 | FGFR1 | 0.49710677 |
112 | TRPM7 | 0.48577164 |
113 | STK4 | 0.48245027 |
114 | PRKD1 | 0.48217565 |
115 | CDK4 | 0.47705804 |
116 | IRAK3 | 0.46927293 |
117 | TYRO3 | 0.46094300 |
118 | STK38 | 0.45897730 |
119 | MAP3K11 | 0.44936925 |
120 | KSR1 | 0.44935208 |
121 | CDC42BPA | 0.44828564 |
122 | PDPK1 | 0.44821112 |
123 | WNK1 | 0.44703359 |
124 | MATK | 0.44548655 |
125 | KSR2 | 0.44474715 |
126 | EGFR | 0.44147616 |
127 | FYN | 0.43102776 |
128 | CDK9 | 0.42944155 |
129 | GSK3A | 0.42493642 |
130 | PRKD2 | 0.41684711 |
131 | MAP3K1 | 0.40608411 |
132 | ALK | 0.40244853 |
133 | PRKAA1 | 0.39885067 |
134 | INSR | 0.38442542 |
135 | ICK | 0.37193728 |
136 | MAP3K5 | 0.36824421 |
137 | NEK6 | 0.35934753 |
138 | SGK1 | 0.35923183 |
139 | RPS6KC1 | 0.32324838 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.04298147 |
2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.67240682 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.58971256 |
4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.20118008 |
5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.06535710 |
6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.02811215 |
7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.93829297 |
8 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.88834002 |
9 | Allograft rejection_Homo sapiens_hsa05330 | 1.84107847 |
10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.70752748 |
11 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.62621964 |
12 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.55620541 |
13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.53043134 |
14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.50286684 |
15 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.47280971 |
16 | ABC transporters_Homo sapiens_hsa02010 | 1.45025581 |
17 | Malaria_Homo sapiens_hsa05144 | 1.41800024 |
18 | Lysine degradation_Homo sapiens_hsa00310 | 1.41329944 |
19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.41151540 |
20 | Insulin resistance_Homo sapiens_hsa04931 | 1.40009429 |
21 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.38282603 |
22 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.32529346 |
23 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.26116953 |
24 | Legionellosis_Homo sapiens_hsa05134 | 1.22143430 |
25 | Bile secretion_Homo sapiens_hsa04976 | 1.21089898 |
26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.20948861 |
27 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.20465787 |
28 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.19642665 |
29 | Leishmaniasis_Homo sapiens_hsa05140 | 1.18638386 |
30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.15432545 |
31 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.10641170 |
32 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.10368050 |
33 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.09954547 |
34 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.08938902 |
35 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.08898319 |
36 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.04673023 |
37 | Measles_Homo sapiens_hsa05162 | 1.01707953 |
38 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.01678758 |
39 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.99042571 |
40 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.96701764 |
41 | Viral myocarditis_Homo sapiens_hsa05416 | 0.91703539 |
42 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.89829287 |
43 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.89157019 |
44 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.89139984 |
45 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.88584693 |
46 | Colorectal cancer_Homo sapiens_hsa05210 | 0.87450154 |
47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.86480463 |
48 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.86273936 |
49 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.86101507 |
50 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.85737786 |
51 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.85659020 |
52 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.84936407 |
53 | Asthma_Homo sapiens_hsa05310 | 0.84775311 |
54 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.84713991 |
55 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.84050037 |
56 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.83459010 |
57 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.83435918 |
58 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.83072496 |
59 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.82295932 |
60 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.82099371 |
61 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.80325450 |
62 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.79895997 |
63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.79641165 |
64 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.79496088 |
65 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.78598913 |
66 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.78018384 |
67 | Peroxisome_Homo sapiens_hsa04146 | 0.77209282 |
68 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.76617077 |
69 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.75935340 |
70 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.75874258 |
71 | Prostate cancer_Homo sapiens_hsa05215 | 0.75556280 |
72 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.75503399 |
73 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.73785525 |
74 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.73468398 |
75 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.72844315 |
76 | Phagosome_Homo sapiens_hsa04145 | 0.72520416 |
77 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.72354357 |
78 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.70389243 |
79 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.70163614 |
80 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.69640495 |
81 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.69336514 |
82 | Long-term potentiation_Homo sapiens_hsa04720 | 0.69286990 |
83 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.68718670 |
84 | Retinol metabolism_Homo sapiens_hsa00830 | 0.68582060 |
85 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.67829729 |
86 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.67441303 |
87 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.67289847 |
88 | Hepatitis C_Homo sapiens_hsa05160 | 0.67268718 |
89 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.67145663 |
90 | Amoebiasis_Homo sapiens_hsa05146 | 0.67110203 |
91 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.67053800 |
92 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.66751525 |
93 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.66600565 |
94 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.66148923 |
95 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.65105712 |
96 | Shigellosis_Homo sapiens_hsa05131 | 0.64646151 |
97 | Platelet activation_Homo sapiens_hsa04611 | 0.64488691 |
98 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.64288223 |
99 | Influenza A_Homo sapiens_hsa05164 | 0.64212887 |
100 | Other glycan degradation_Homo sapiens_hsa00511 | 0.64023685 |
101 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.63483222 |
102 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.63377909 |
103 | Histidine metabolism_Homo sapiens_hsa00340 | 0.62195675 |
104 | Glioma_Homo sapiens_hsa05214 | 0.61436381 |
105 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.61394279 |
106 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.61096553 |
107 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60830182 |
108 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.60747756 |
109 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60728042 |
110 | Salmonella infection_Homo sapiens_hsa05132 | 0.60584002 |
111 | Adherens junction_Homo sapiens_hsa04520 | 0.60254288 |
112 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.60243603 |
113 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.60054938 |
114 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.60011616 |
115 | Hepatitis B_Homo sapiens_hsa05161 | 0.59802033 |
116 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.59027809 |
117 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.59012934 |
118 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.59000432 |
119 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.57500824 |
120 | Apoptosis_Homo sapiens_hsa04210 | 0.57350048 |
121 | Circadian rhythm_Homo sapiens_hsa04710 | 0.57279693 |
122 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57160195 |
123 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.57106205 |
124 | HTLV-I infection_Homo sapiens_hsa05166 | 0.56915625 |
125 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.56561780 |
126 | Endocytosis_Homo sapiens_hsa04144 | 0.56293400 |
127 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.56254564 |
128 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.55410503 |
129 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.54795236 |
130 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.54772736 |
131 | Focal adhesion_Homo sapiens_hsa04510 | 0.54372947 |
132 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.53896977 |
133 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.53725935 |
134 | Tuberculosis_Homo sapiens_hsa05152 | 0.53463696 |
135 | Pertussis_Homo sapiens_hsa05133 | 0.52916818 |
136 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.52842968 |
137 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.52726565 |
138 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.52631069 |
139 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.52591386 |
140 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.52428162 |
141 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.51726205 |
142 | Endometrial cancer_Homo sapiens_hsa05213 | 0.50837812 |
143 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.50384965 |
144 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49321807 |
145 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.49243533 |
146 | Renin secretion_Homo sapiens_hsa04924 | 0.47519528 |
147 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.47060946 |